Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 89.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,737 shares of the company's stock after selling 98,400 shares during the period. Handelsbanken Fonder AB's holdings in Molina Healthcare were worth $4,241,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. LRT Capital Management LLC purchased a new stake in Molina Healthcare in the fourth quarter valued at approximately $464,000. CWM LLC boosted its position in Molina Healthcare by 3.7% in the 4th quarter. CWM LLC now owns 1,446 shares of the company's stock worth $522,000 after purchasing an additional 51 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Molina Healthcare by 1.9% in the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 5,734 shares of the company's stock worth $2,072,000 after purchasing an additional 106 shares in the last quarter. Signaturefd LLC boosted its position in Molina Healthcare by 5.0% in the 4th quarter. Signaturefd LLC now owns 1,045 shares of the company's stock worth $378,000 after purchasing an additional 50 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its position in Molina Healthcare by 37.7% in the 4th quarter. Lindbrook Capital LLC now owns 219 shares of the company's stock worth $79,000 after purchasing an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the transaction, the director now directly owns 12,207 shares of the company's stock, valued at approximately $4,688,220.42. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the firm's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares of the company's stock, valued at approximately $4,688,220.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Mark Lowell Keim sold 15,000 shares of the firm's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at $14,121,423.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,711 shares of company stock valued at $6,472,517. 1.10% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have commented on MOH shares. Bank of America lowered Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective on the stock. in a research report on Thursday, March 28th. Stephens restated an "equal weight" rating and issued a $390.00 price objective on shares of Molina Healthcare in a research report on Thursday. Cantor Fitzgerald restated an "overweight" rating and issued a $406.00 price objective on shares of Molina Healthcare in a research report on Thursday, April 4th. Truist Financial upped their price objective on Molina Healthcare from $435.00 to $460.00 and gave the stock a "buy" rating in a research report on Tuesday, February 20th. Finally, Wells Fargo & Company lowered their price objective on Molina Healthcare from $440.00 to $410.00 and set an "equal weight" rating on the stock in a research report on Monday, April 15th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $396.09.

Molina Healthcare Price Performance

Shares of MOH stock traded down $10.07 during trading hours on Friday, hitting $342.23. 593,393 shares of the company's stock were exchanged, compared to its average volume of 404,234. The firm has a 50 day moving average of $391.53 and a two-hundred day moving average of $371.87. Molina Healthcare, Inc. has a fifty-two week low of $266.35 and a fifty-two week high of $423.92. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. The firm has a market cap of $20.05 billion, a P/E ratio of 19.12, a P/E/G ratio of 1.03 and a beta of 0.47.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating the consensus estimate of $5.46 by $0.27. Molina Healthcare had a return on equity of 30.99% and a net margin of 2.99%. The firm had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. During the same period in the prior year, the company earned $5.81 EPS. The firm's revenue was up 21.9% compared to the same quarter last year. Sell-side analysts forecast that Molina Healthcare, Inc. will post 23.62 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.